Blood and Marrow Transplant Group of Georgia at Northside Hospital is a collaboration between The Blood and Marrow Transplant Group of Georgia (BMTGA) and Northside Hospital. The NSH-BMT Program is one of the
largest clinical transplant programs in the United States, serving patients undergoing bone marrow/stem cell transplant therapy and providing primary leukemia treatment. NSH-BMT staff includes nationally recognized physicians, mid-level practitioners,
nurses, coordinators, clinical BMT PharmD.'s, a dedicated health psychologist, nutritionists, physical therapists and ancillary specialists.
Colorado Blood Cancer Institute (CBCI) is a new program established by the expert physicians who have served Rocky Mountain Blood and Marrow Transplant Program patients for more
than 15 years. CBCI was developed to provide state-of-the-art treatment for blood cancers such as leukemia, lymphoma and multiple myeloma. CBCI is a FACT-accredited program for both autologous and allogeneic transplants, performing related and
unrelated donor transplants including cord blood transplants. CBCI conducts cutting edge clinical research, testing innovative treatments for patients with blood cancers and bone marrow diseases. Referral to a blood cancer specialist early after
diagnosis allows for full evaluation of treatment options and the development of a treatment plan including access to approximately 50 clinical trials. The physicians and staff can discuss research studies to ensure that patients receive the most
progressive therapies available.
The University of Iowa Holden Comprehensive Cancer Center is Iowa's only NCI-designated comprehensive cancer center. Nearly 1,200 staff and cancer center members, including faculty from 41 academic departments, collaborate to drive Holden's research, education, and patient care missions. At any given time, Holden participates in more than 300 active clinical trials. Holden is the recipient of two NCI Specialized Program of Research Excellence (SPORE) grants, including the first and only neuroendocrine tumor SPORE.
The University of Kansas Cancer Center is an NCI-designated cancer center and a U.S. News & World Report Top 50 cancer program. Kansas's largest, most experienced blood and
marrow transplant (BMT) program has performed more than 3,000 transplants, averaging 300 per year. Patients have access to the widest range of treatment options, including clinical trials. The Center's BMT program provides autologous, allogeneic,
haploidentical, and cord blood transplantation. A multidisciplinary team, including nurse navigators, provides personalized care in the 49-bed inpatient unit and outpatient Cancer and Therapeutic Blood Treatment Center. The Center's advances in
half-matched donor transplant (haploidentical) allows for a broader range of donors, increased donor matches, shorter transplant wait times, and, ultimately, more saved lives. The Cancer Center is also part of the ACS Commission on Cancer, FACT,
NMDP, BMT-CTN Core Center, the Myeloproliferative Disorders Research Consortium, and SWOG, and is an ANCC Magnet hospital.
New York Oncology Hematology (NYOH) is the leading provider of community-based cancer care services in New York State’s capital region. The NYOH medical staff includes 35 board certified
physicians who specialize in the care of patients with cancer (medical oncology and radiation oncology) and blood-related disorders (hematology). With a patient care team of more than 300 oncology certified nurses, pharmacists, laboratory technologists,
radiation therapists and support personnel and seven, easy-access locations, NYOH is the renowned cancer care provider of choice for thousands of area residents. NYOH physicians include 5 dedicated Hematologists mostly centered at our office at
Albany Medical Center, where it also provides an outpatient autologous bone marrow stem cell transplantation service.
Northern Light Cancer Care is accredited through the American College of Surgeons — Commission on Cancer with commendation as Maine's only Comprehensive
Community Cancer Program recognized for outstanding achievement, and is proud to offer many national clinical trials locally. EMMC received the 2014 American College of Surgeons – Commission on Cancer Outstanding Achievement Award.
Pacific Cancer Care has been a leading provider of oncology and hematology services for over 30 years. Previously known as Monterey Bay Oncology and Los Palos Oncology and Hematology, the
group has grown to become the major provider of oncology and hematology services in Central California. PCC is a place where experienced physicians care for their patients with the support of highly skilled nurses and a dedicated staff. Equipped with
all the latest advances, the PCC team offers patients a complete, comprehensive program across the continuum of care. PCC patients receive the best possible care, which is both personalized, comprehensive and advanced, in a caring environment that
is close to home.
Smilow Cancer Hospital at St. Francis is one of the region’s leading cancer treatment centers, located on the campus of St. Francis Hospital,
a 600-bed community teaching hospital in Hartford, CT. The 45,000 square foot Cancer Center opened in 1993, and houses radiation oncology, medical oncology, and hematology, along with a broad network of support services. Within the cancer center,
the Lea Economos Hematology Center for Clinical Research includes 5 physicians whose clinical focus is patients with hematologic malignancies, with access to cutting edge technology and clinical trials sponsored by NCI cooperative groups, pharmaceutical
companies, and academic partners. This care is provided by specialized nurses, midlevel providers, physicians and clinical navigators in a patient- and family-focused environment.
West Cancer Center is a community-based oncology practice located in Memphis, TN. For over 34 years, the dedicated physicians and staff at West Cancer Center have been providing the highest
quality care and cutting edge therapies for their patients located in the Midsouth. Our multidisciplinary physician group is comprised of 35 specialists in medical oncology, hematology, gynecologic oncology, breast surgery, radiation oncology,
endocrinology, diagnostic and interventional radiology, as well as pain and palliative care. The clinical research program has successfully conducted over 350 phase I – III clinical trials.
West Michigan Cancer Center and Institute for Blood Disorders (WMCC) was founded in 1994 as a not-for-profit collaboration between Borgess Health and Bronson Methodist Hospital. WMCC offers comprehensive,
multidisciplinary, integrative cancer treatment. WMCC is affiliated with the Cancer Research Consortium of West Michigan (CRCWM), a member of the National Cancer Institute Clinical Oncology Research Program (NCORP). It was one of the nation's
first oncology practices to be recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO). The Center is accredited by the American College of Radiation
Oncology (ACRO), the American College of Radiology Imaging Network (ACRIN), and the National Accreditation Program for Breast Centers (NAPBC).